Tag Archives: Treatment

Breast cancer treatment may ‘send tumour cells to sleep instead of killing them’

Breast cancer treatment may ‘send tumour cells to sleep instead of killing them’ and allow the disease to return years later, study warns Scientists tested cancer cells in the lab in response to hormone therapy  Some of them became dormant, which could explain why cancer returns They also travel round the body easier, which causes… Read More »

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis Print this page NORTH CHICAGO, Ill., Aug. 16, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), a 15 mg, once-daily oral… Read More »

FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults

FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults Print this page Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive… Read More »

Woman, 23, with stage four incurable cancer sets out to raise £300,000 to fund private treatment

Woman, 23, with stage four incurable cancer faces a race against time to raise £300K for private treatment that’s her ‘last hope’ of survival Daisy Ellis, 23, from Northamptonshire, diagnosed with a rare soft tissue cancer Went through 20 chemotherapy cycles and 50 radiotherapy sessions in 2 years Now says she has ‘run out of options’ and… Read More »

FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia

FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia Print this page July 24, 2019 — The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection. Severe hypoglycemia occurs when a patient’s… Read More »